Search

Background: The COVID-19 pandemic had affected population health throughout the world. Few studies had focused on post-COVID19 complications detection using multi-slice CT scans. Our trial aimed to assess the value of cardiac CT utility during the COVID-19 pandemic for the detection of cardiac complications and correlation with the severity scoring system for chest manifestations. Since the beginning of COVID-19 outbreak, cardiac computed tomography (CT) had a sudden increased value and use with a huge reduction in face-to-face patient care and elective diagnostic testing. This study started from May 2021 to April 2022 in a single cardiac CT centre. This prospective cohort trial was conducted on 40 patients proved to have COVID-19 infection by positive RT-PCR test for COVID-19 and/or CT chest manifestations. CT results were reviewed and compared to echocardiography and/or catheterization data. Results: In the CT severity score, the more severe score for COVID-19 infection was noted in cases with coronary artery occlusion and pulmonary embolic diseases. Meanwhile, the mild and moderate severity score groups developed myocarditis, pericarditis, and dilated cardiomyopathy, respectively, with statically significant differences with p-value= 0.007 for coronary artery disease (CAD) and 0.026 for pulmonary embolism. The significance of echocardiography examination was noted in cases with pericarditis and dilated cardiomyopathy, with p-value= 0.018 for pericarditis and 0.01 for dilated cardiomyopathy. Conclusions: MSCT is a very useful technique to for patients presenting with suspected post-COVID cardiac complications, in addition to severity scoring of chest involvement, also providing its correlation with the occurrence of cardiac complications.

Objective: The aim of this work is to compare the clinical, functional, and ultrasonographic outcomes of focused, radial, and combined extracorporeal shock-wave therapy (ESWT) in the treatment of c...

Objective: to evaluate the role of US C 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.